web analytics
17 C
Munich
Tuesday, August 3, 2021

LifeAir G1 Portable Ventilator; the Rise of Forwardly Inc.  (OTCMKTS: FORW)

Forwardly Inc.  (OTCMKTS: FORW) is making a powerful move up the charts over the past few weeks emerging as a volume leader and exploding out of the subs and moving well into penny land. The Company is led by stock whizz George Sharp of TSNP fame who has implemented a significant share reduction slicing the authorized in half and committing itself to avoiding a reverse split of the stock.

FORW recently secured exclusive US distribution rights to LifeAir, a patent pending, non-invasive ventilator currently under development by Ligand Innovation Global, a Canadian corporation. A newer iteration of the LifeAir ventilator is currently being engineered for a summer 2020 submission to the US Food and Drug Administration (“FDA”) and Canada Health in the hopes of obtaining fast track approval. In June the Company filed its application to raise up to $15 million under Regulation A+. More recently FORW received funding commitments of $500,000 of an anticipated total of $1.3 million in financing and will itself fund Ligand Global Innovation’s development of its latest prototype of the LifeAir G1 Portable Ventilator.

Forwardly Inc.  (OTCMKTS: FORW) operating out of Boulder City, Nevada is a public company seeking opportunities to partner in fresh ideas. The company trades on the OTC Market under the symbol FORW. The company is headed by George Sharp, a former consultant to OTC Markets and a stock whizz who gets the job done right. The Company used to be Guard Dog, Inc and changed its name to Forwardly in January 2020.

LifeAir™ | Breathe Medical Devices, Inc.In June the Company filed its application to raise up to $15 million under Regulation A+. The filing includes details about Forwardly’s June 1st formation of “Breathe Medical Devices, Inc.”, a wholly owned Wyoming corporation. This subsidiary will be the operating arm for Forwardly’s recent acquisition of the exclusive US distribution rights to LifeAir, a patent pending, non-invasive ventilator currently under development by Ligand Innovation Global, a Canadian corporation.

A newer iteration of the LifeAir ventilator is currently being engineered for a summer 2020 submission to the US Food and Drug Administration (“FDA”) and Canada Health in the hopes of obtaining fast track approval. A demonstration of a prototype of the LifeAir ventilator is available for viewing at www.LigandGlobal.com. Forwardly has retained a consultant to develop its own website for the subsidiary, which is expected to be published in the next 5 to 10 days and will be located at the url “BreatheMedicalDevices.com”.

To Find out the inside Scoop on FORW Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

FORW

On August 31 FORW announced it has already received funding commitments of $500,000 of an anticipated total of $1.3 million in financing and will itself fund Ligand Global Innovation’s development of its latest prototype of the LifeAir G1 Portable Ventilator.

As announced in a June 15, 2020 press release, Forwardly, through its wholly owned subsidiary, Breathe Medical Devices, Inc., has obtained the exclusive US distribution rights to the LifeAir line of ventilator products. As part of the agreement, Forwardly also has the option to acquire up to 25% ownership interest in Ligand. Forwardly’s funding of the development of the new LifeAir G1 prototype will be applied towards the exercise of this option.

Funding for the new LifeAir G1 prototype is being raised by Forwardly through the exercise of warrants issued to purchasers of a series of debentures issued in 2019 with an aggregate total of $300,000 (the “2020 debentures”), as well as purchasers of a new series of non-toxic debentures for an aggregate total of up to $1 million. These new debentures are convertible to common stock at $.012 and set to mature in March 2022 (the “2022 debentures”).

FORW CEO George Sharp commented, “With the business world being slowed to a crawl as a result of the current pandemic, Forwardly management deemed it more expeditious to raise funds privately to enable the development of the next generation of LifeAir G1, rather than wait for the SEC’s approval of the Regulation A+ application and the subsequent time required to fund. We found our private funders to be more than eager to participate, by exercising outstanding warrants and purchasing our new series of debentures. I am proud that our private funding sources continue to support our endeavors.

https://twitter.com/Eppbankmoney/status/1332385479954755585

For more on FORW Subscribe Right Now!

FORW is making a powerful move up the charts over the past few weeks emerging as a volume leader and exploding out of the subs and moving well into penny land. The Company is led by securities whizz George Sharp of TSNP fame who has implemented a significant share reduction slicing the authorized in half and committing itself to avoiding a reverse split of the stock. FORW recently secured exclusive US distribution rights to LifeAir, a patent pending, non-invasive ventilator currently under development by Ligand Innovation Global, a Canadian corporation. A newer iteration of the LifeAir ventilator is currently being engineered for a summer 2020 submission to the US Food and Drug Administration (“FDA”) and Canada Health in the hopes of obtaining fast track approval. In June the Company filed its application to raise up to $15 million under Regulation A+. More recently FORW received funding commitments of $500,000 of an anticipated total of $1.3 million in financing and will itself fund Ligand Global Innovation’s development of its latest prototype of the LifeAir G1 Portable Ventilator. We will be updating on FORW when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with FORW.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in FORW either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.